Cargando…

Identification of molecular subtypes based on inflammatory response in lower-grade glioma

BACKGROUND: Inflammatory response is an important characteristic affecting prognosis and therapeutic response in lower-grade glioma (LGG). However, the molecular subtypes based on inflammatory response are still under exploitation. METHODS: The RNA sequencing, somatic mutation, and corresponding cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wanzun, Gao, Jing, Zhang, Haojiong, Chen, Li, Qiu, Xianxin, Huang, Qingting, Hu, Jiyi, Kong, Lin, Lu, Jiade J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526248/ https://www.ncbi.nlm.nih.gov/pubmed/36180938 http://dx.doi.org/10.1186/s41232-022-00215-9

Ejemplares similares

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2021)

Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma
por: Lin, Wanzun, et al.
Publicado: (2021)

VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy
por: Lin, Wanzun, et al.
Publicado: (2021)

Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study
por: Qiu, Xianxin, et al.
Publicado: (2022)

Preliminary clinical outcomes of head and neck squamous cell carcinoma treated with particle beam radiation therapy
por: Huang, Qingting, et al.
Publicado: (2023)

Perfusion MR prior to radiotherapy is a strong predictor of survival in high-grade gliomas after proton and carbon ion radiotherapy
por: Qiu, Xianxin, et al.
Publicado: (2022)

A Comparison Study of Machine Learning (Random Survival Forest) and Classic Statistic (Cox Proportional Hazards) for Predicting Progression in High-Grade Glioma after Proton and Carbon Ion Radiotherapy
por: Qiu, Xianxin, et al.
Publicado: (2020)

Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation
por: Lin, Wanzun, et al.
Publicado: (2023)

Particle Beam Radiation Therapy for Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinuses
por: Hu, Weixu, et al.
Publicado: (2020)

Particle beam radiation therapy for sinonasal malignancies: Single institutional experience at the Shanghai Proton and Heavy Ion Center
por: Hu, Weixu, et al.
Publicado: (2020)

Intensity-modulated proton and carbon-ion radiation therapy in the management of major salivary gland carcinomas
por: Huang, Qingting, et al.
Publicado: (2022)

Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies
por: Yang, Jing, et al.
Publicado: (2022)

Comparison of the efficacy and toxicity of postoperative proton versus carbon ion radiotherapy for head and neck cancers
por: Huang, Qingting, et al.
Publicado: (2022)

The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx
por: Hu, Jiyi, et al.
Publicado: (2022)

Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center
por: Kong, Lin, et al.
Publicado: (2020)

Particle Beam Radiation Therapy for Skull Base Sarcomas
por: Yang, Jing, et al.
Publicado: (2020)

Clinical outcomes of carbon‐ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020)

Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma
por: Hu, Jiyi, et al.
Publicado: (2021)

Outcomes of orbital malignancies treated with eye-sparing surgery and adjuvant particle radiotherapy: a retrospective study
por: Hu, Weixu, et al.
Publicado: (2019)

Intensity-modulated particle beam radiation therapy in the management of olfactory neuroblastoma
por: Hu, Weixu, et al.
Publicado: (2020)

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
por: Guan, Xiaowei, et al.
Publicado: (2014)

Particle beam radiation therapy for head and neck rhabdomyosarcoma in adults
por: Yang, Jing, et al.
Publicado: (2022)

Mesenchymal Stem Cells Inhibits Migration and Vasculogenic Mimicry in Nasopharyngeal Carcinoma Via Exosomal MiR-125a
por: Wan, Fangzhu, et al.
Publicado: (2022)

Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial
por: Kong, Lin, et al.
Publicado: (2019)

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy
por: Lin, Wanzun, et al.
Publicado: (2020)

The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine
por: Guan, Xiyin, et al.
Publicado: (2019)

Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study
por: Hu, Jiyi, et al.
Publicado: (2022)

Intensity‐Modulated Proton and Carbon‐Ion Radiation Therapy in the Management of Head and Neck Sarcomas
por: Yang, Jing, et al.
Publicado: (2019)

Volumetric parameters derived from FLT-PET performed at completion of treatment predict efficacy of Carbon-ion Radiotherapy in patients with locally recurrent Nasopharyngeal Carcinoma
por: Hu, Jiyi, et al.
Publicado: (2020)

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
por: Lin, Wanzun, et al.
Publicado: (2020)

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
por: Ye, Liguo, et al.
Publicado: (2021)

Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma
por: Sun, Chen, et al.
Publicado: (2022)

Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline
por: Sienkiewicz, Karolina, et al.
Publicado: (2022)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

Development of a normal tissue complication probability (NTCP) model using an artificial neural network for radiation-induced necrosis after carbon ion re-irradiation in locally recurrent nasopharyngeal carcinoma
por: Wang, Tian, et al.
Publicado: (2022)

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
por: Wang, Zhi-liang, et al.
Publicado: (2022)

Machine learning-based identification of lower grade glioma stemness subtypes discriminates patient prognosis and drug response
por: Zhou, Hongshu, et al.
Publicado: (2023)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

Upregulated necroptosis-pathway-associated genes are unfavorable prognostic markers in low-grade glioma and glioblastoma multiforme
por: Dong, Yuanli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_adou5i4id08l6udgjludlidtli